Structure-function studies of apoA-I variants: Site-directed mutagenesis and natural mutations

Journal of Lipid Research

Volumn 43, Issue 8, 2002, Pages 1283-1292

  Sviridov, Dmitri ^a   Hoang, Anh ^a   Huang, Wei ^b,c   Sasaki, Jun ^b,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Apolipoprotein A I; Atherosclerosis; Cholesterol efflux; Cholesterol transport; High density lipoprotein; Thin layer chromatography

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; LIPID; PHOSPHOLIPID;

ALPHA HELIX; ARTICLE; CELL INTERACTION; CELL STRAIN HEPG2; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; GENE FUNCTION; GENE MUTATION; GENE STRUCTURE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

EID: 0036689537     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.m100437-jlr200     Document Type: Article

References (53)

1. The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function
2. Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks
3. A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein
4. Arrangement of apolipoprotein A-I in reconstituted high-density lipoprotein disks: An alternative model based on fluorescence resonance energy transfer experiments
5. Apolipoprotein A-I: Structure-function relationships
6. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I
7. The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation
8. Alteration in apolipoprotein A-I 22-mer repeat order results in a decrease in lecithin: Cholesterol acyltransferase reactivity
9. Identification of a sequence of apolipoprotein A-I associated with activation of lecithin:cholesterol acyltransferase
10. Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles
11. Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants
12. Only the two end helixes of eight tandem amphipathic helical domains of human apo A-I have significant lipid affinity. Implications for HDL assembly
13. Phospholipid binding and lecithin-cholesterol acyltransferase activation properties of apolipo-protein A-I mutants
14. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein
15. A single amino acid deletion in the carboxy terminal of apolipoprotein A-I impairs lipid binding and cellular interaction
16. A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma
17. Apolipoprotein A-IGiessen (Pro143-Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferase
18. A novel homozygous missense mutation in the apo A-I gene with apo A-I deficiency
19. Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165→Arg)
20. Apolipoprotein A-IFIN (Leu159→Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts
21. Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L) Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers
22. A novel mutant, ApoA-I nichinan (Glu235→0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells
23. Effectivity of expression of mature forms of mutant human apolipoprotein A-I
24. Production of mature human apolipoprotein A-I in a baculovirus-insect cell system: Propeptide is not essential for intracellular processing but may assist rapid secretion
25. Recombinant proapoA-I(Lys107del) shows impaired lipid binding associated with reduced binding to plasma high density lipoprotein
26. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
27. Studies on the formation, separation, and characterization of cyanogen bromide fragments of human AI apolipoprotein
28. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions
29. Defined apolipoprotein A-1 conformations in reconstituted high density lipoprotein discs
30. Transport of cholesterol from the endoplasmic reticulum to the plasma membrane
31. Cholesterol and vesicular stomatitis virus G protein take separate routes from the endoplasmic reticulum to the plasma membrane
32. Efflux of intracellular vs plasma membrane cholesterol in HepG2 cells: Different availability and regulation by apolipoprotein A-I
33. Deletion of the pro-peptide of apolipoprotein A-I reduces protein expression, but stimulates effective conversion of preβ-HDL to α-HDL
34. Pathway of cholesterol efflux from human hepatoma cells. Biochim
35. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines
36. Effects of enrichment of fibroblasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein A-I
37. Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispertion
38. Structural and functional properties of full-length and truncated human proapolipoprotein AI expressed in Escherichia coli
39. Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid
40. Characterization of two new human apolipoprotein A-I variants: Apolipoprotein A-I Tsushima (Trp-108→Arg) and A-I Hita (Ala-95→Asp)
41. Identification of two apolipoprotein variants, A-I Karatsu (Tyr 100→His) and A-I Kurume (His 162→Gln)
42. Isolation and characterization of human apolipoprotein A-I Fukuoka (110 Glu-Lys). A novel apolipoprotein variant
43. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein
44. Properties of an N-terminal proteolytic fragment of apolipoprotein AI in solution and in reconstituted high density lipoproteins
45. The role of apolipoprotein AI domains in lipid binding
46. Deletion of the C-terminal domain of apolipoprotein A-I impairs cell surface binding and lipid efflux in macrophage
47. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes
48. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-1
49. Prebeta-1 HDL in plasma of normolipidemic individuals: Influences of plasma lipoproteins, age, and gender
50. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein
51. Plasma membrane caveolae mediate the efflux of cellular free cholesterol
52. Distinct central amphipathic alpha-helices in apolipoprotein A-I contribute to the in vivo maturation of high density lipoprotein by either activating lecithin-cholesterol acyl-transferase or binding lipids
53. Evidence for a central apolipoprotein A-I domain loosely bound to lipids in discoidal lipoproteins that is capable of penetrating the bilayer of phospholipid vesicles